Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 270

1.

A human-specific, truncated α7 nicotinic receptor subunit assembles with full-length α7 and forms functional receptors with different stoichiometries.

Lasala M, Corradi J, Bruzzone A, Esandi MDC, Bouzat C.

J Biol Chem. 2018 Jul 6;293(27):10707-10717. doi: 10.1074/jbc.RA117.001698. Epub 2018 May 21.

PMID:
29784875
2.

CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment.

Kalmady SV, Agrawal R, Venugopal D, Shivakumar V, Amaresha AC, Agarwal SM, Subbanna M, Rajasekaran A, Narayanaswamy JC, Debnath M, Venkatasubramanian G.

J Neural Transm (Vienna). 2018 Apr;125(4):741-748. doi: 10.1007/s00702-017-1833-5. Epub 2018 Jan 5.

PMID:
29305655
3.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Cristalli C, Mantovani V, Pae CU, Serretti A.

J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.

PMID:
29164477
4.

The α7-nACh nicotinic receptor and its role in memory and selected diseases of the central nervous system.

Baranowska U, Wiśniewska RJ.

Postepy Hig Med Dosw (Online). 2017 Jul 30;71(0):633-648. Review.

5.

Septal Cholinergic Neuromodulation Tunes the Astrocyte-Dependent Gating of Hippocampal NMDA Receptors to Wakefulness.

Papouin T, Dunphy JM, Tolman M, Dineley KT, Haydon PG.

Neuron. 2017 May 17;94(4):840-854.e7. doi: 10.1016/j.neuron.2017.04.021. Epub 2017 May 4.

6.

GeneAnalytics Pathway Analysis and Genetic Overlap among Autism Spectrum Disorder, Bipolar Disorder and Schizophrenia.

Khanzada NS, Butler MG, Manzardo AM.

Int J Mol Sci. 2017 Feb 28;18(3). pii: E527. doi: 10.3390/ijms18030527.

7.

Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.

Koukouli F, Rooy M, Tziotis D, Sailor KA, O'Neill HC, Levenga J, Witte M, Nilges M, Changeux JP, Hoeffer CA, Stitzel JA, Gutkin BS, DiGregorio DA, Maskos U.

Nat Med. 2017 Mar;23(3):347-354. doi: 10.1038/nm.4274. Epub 2017 Jan 23.

8.

Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes.

Yin J, Chen W, Yang H, Xue M, Schaaf CP.

Sci Rep. 2017 Jan 3;7:39941. doi: 10.1038/srep39941.

9.

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.

Klemettilä JP, Kampman O, Solismaa A, Lyytikäinen LP, Seppälä N, Viikki M, Hämäläinen M, Moilanen E, Mononen N, Lehtimäki T, Leinonen E.

Eur Psychiatry. 2017 Feb;40:13-19. doi: 10.1016/j.eurpsy.2016.07.004. Epub 2016 Nov 10.

PMID:
27837667
10.

Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder.

Olincy A, Blakeley-Smith A, Johnson L, Kem WR, Freedman R.

J Autism Dev Disord. 2016 Dec;46(12):3812-3817.

PMID:
27565651
11.

Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.

Pershing ML, Phenis D, Valentini V, Pocivavsek A, Lindquist DH, Schwarcz R, Bruno JP.

Psychopharmacology (Berl). 2016 Oct;233(21-22):3725-3735. Epub 2016 Aug 16.

12.

15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes.

Forsingdal A, Fejgin K, Nielsen V, Werge T, Nielsen J.

Transl Psychiatry. 2016 Jul 26;6(7):e860. doi: 10.1038/tp.2016.125.

13.

Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.

Freund RK, Graw S, Choo KS, Stevens KE, Leonard S, Dell'Acqua ML.

Neurosci Lett. 2016 Aug 3;627:1-6. doi: 10.1016/j.neulet.2016.05.043. Epub 2016 May 24.

14.

Cholinergic modulation of auditory P3 event-related potentials as indexed by CHRNA4 and CHRNA7 genotype variation in healthy volunteers.

Hyde M, Choueiry J, Smith D, de la Salle S, Nelson R, Impey D, Baddeley A, Aidelbaum R, Millar A, Knott V.

Neurosci Lett. 2016 Jun 3;623:36-41. doi: 10.1016/j.neulet.2016.04.040. Epub 2016 Apr 22.

PMID:
27109789
16.

An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.

Gass N, Weber-Fahr W, Sartorius A, Becker R, Didriksen M, Stensbøl TB, Bastlund JF, Meyer-Lindenberg A, Schwarz AJ.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1150-60. doi: 10.1016/j.euroneuro.2016.03.013. Epub 2016 Mar 28.

17.

A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.

Nilsson SR, Celada P, Fejgin K, Thelin J, Nielsen J, Santana N, Heath CJ, Larsen PH, Nielsen V, Kent BA, Saksida LM, Stensbøl TB, Robbins TW, Bastlund JF, Bussey TJ, Artigas F, Didriksen M.

Psychopharmacology (Berl). 2016 Jun;233(11):2151-63. doi: 10.1007/s00213-016-4265-2. Epub 2016 Mar 17.

18.

15q13.3 duplication in two patients with childhood-onset schizophrenia.

Zhou D, Gochman P, Broadnax DD, Rapoport JL, Ahn K.

Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):777-83. doi: 10.1002/ajmg.b.32439. Epub 2016 Mar 10.

19.

CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling.

Xiang T, Yu F, Fei R, Qian J, Chen W.

Oncol Rep. 2016 Feb;35(2):999-1005. doi: 10.3892/or.2015.4462. Epub 2015 Nov 27.

PMID:
26719016
20.

Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.

Ross RG, Hunter SK, Hoffman MC, McCarthy L, Chambers BM, Law AJ, Leonard S, Zerbe GO, Freedman R.

Am J Psychiatry. 2016 May 1;173(5):509-16. doi: 10.1176/appi.ajp.2015.15091188. Epub 2015 Dec 7. Erratum in: Am J Psychiatry. 2016 Jul 1;173(7):735.

Supplemental Content

Loading ...
Support Center